Stockreport

This Stock Is Up By 285% This Year But Could Still Jump By 53%, According to Wall Street [Yahoo! Finance]

Nektar Therapeutics  (NKTR) 
Last nektar therapeutics earnings: 2/27 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.nektar.com/investor-relations
PDF This medicine could disrupt the large and competitive eczema treatment market. Nektar could match Wall Street's estimates in the next year, but the stock remains risk [Read more]